Accessibility Menu
 
Avax Technologies logo

Avax Technologies

(OTC) AVXT

Current PriceN/A
Market CapN/A
Since IPO (1996)-100%
5 Year-99%
1 Year-90%
1 Month+0%

Avax Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$734.54K

Net Income (TTM)

$7.38M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

AVXT News

No articles available.

AVXT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Avax Technologies

Industry

Biotechnology

Headquarters

Philadelphia, PA 19130, US

AVXT Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

11%

Net Income Margin

-10%

Return on Equity

-3%

Return on Capital

2%

Return on Assets

-87%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$617.38K

Operating Income

$6.69M

EBITDA

$6.11M

Operating Cash Flow

$4.73M

Capital Expenditure

$127.40K

Free Cash Flow

$4.86M

Cash & ST Invst.

$5.90M

Total Debt

$0.00

Avax Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2008YOY CHG

Revenue

$199.81K

+108.4%

Gross Profit

$199.81K

+108.4%

Gross Margin

100.00%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

9

N/A

Net Income

$1.87M

-0.3%

EBITDA

$1.80M

+5.1%

Quarterly Fundamentals

Name
Q3 2008YOY CHG

Net Cash

$344.95K

-95.5%

Accounts Receivable

$43.57K

-73.1%

Inventory

$3.65K

-74.8%

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-86.94%

N/A

Return on Invested Capital

1.98%

N/A

Free Cash Flow

$925.56K

+23.8%

Operating Cash Flow

$875.91K

+21.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
USRMU.S. Stem Cell, Inc.
$0.00+0.00%
DNAGDNAPrint Genomics, Inc.
$0.00+0.00%
BRAXFBraxia Scientific Corp.
$0.00+0.00%
MRPIMera Pharmaceuticals, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About AVXT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.